Global Biosimilars Market – Industry Analysis, Size, Share, Growth, Trends & Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biosimilars Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027” report has been added to ResearchAndMarkets.com’s offering.

Biosimilars Market – Scope of the Report

This report on the global biosimilars market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global biosimilars market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global biosimilars market for the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global biosimilars market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global biosimilars market. The next section of the global biosimilars report highlights the USPs, which include regulatory scenarios for biosimilars globally, Biosimilars pipeline analysis, and potential product launches in the global biosimilars market.

The report delves into the competitive landscape of the global biosimilars market. Key players operating in the global biosimilars market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global biosimilars market report.

Key Questions Answered

• What is the sales/revenue generated by biosimilar products across all regions during the forecast period?
• What are the key trends in the biosimilars market?
• What are the major drivers, restraints, and opportunities in the market?
• In which region is the biosimilars market set to expand at the fastest CAGR during the forecast period?
• Which segment will have the highest revenue globally in 2027 and which product segment will expand at the fastest CAGR during the forecast period?

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary: Global Biosimilars Market

5. Market Overview

5.1. Definition

5.2. Market Indicators

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

6. Market Outlook

6.1. Global Biosimilars Market Analysis and Forecast, 2017-2027

6.2. Global Biosimilars Market Outlook

6.3. Entry Barriers to Biosimilars Market

6.4. Factors Driving the Adoption of Biosimilars

6.5. Pipeline Analysis

6.6. Regulatory Scenario Assessment

6.7. Key Industry Developments

7. Global Biosimilars Market Analysis and Forecast, by Product

7.1. Introduction

7.2. Biosimilars Market Value Forecast, by Product, 2017-2027

7.2.1. Recombinant Glycosylated Proteins

7.2.1.1. Monoclonal Antibodies

7.2.1.2. Erythropoietin

7.2.1.3. Others

7.2.2. Recombinant Non-glycosylated Proteins

7.2.2.1. Insulin

7.2.2.2. Granulocyte Colony Stimulating Factor

7.2.2.3. Recombinant Human Growth Factor

7.2.2.4. Interferons

7.2.3. Recombinant Peptides

7.3. Market Attractiveness, by Product

8. Global Biosimilars Market Analysis and Forecast, by Indication

8.1. Introduction

8.2. Biosimilars Market Value Forecast, by Indication, 2017-2027

8.2.1. Chronic Diseases

8.2.2. Oncology

8.2.3. Autoimmune Diseases

8.2.4. Infectious Diseases

8.2.5. Blood Disorders

8.2.6. Growth Hormone Deficiency

8.2.7. Others

8.3. Market Attractiveness By Material

9. Global Biosimilars Market Analysis and Forecast, by Region

9.1. Regional Outlook

9.2. Global Scenario

9.3. Introduction

9.4. Biosimilars Market Value Forecast, by Region

9.5. Market Attractiveness, by Region

10. North America Biosimilars Market Analysis and Forecast

10.1. Key Findings

10.2. North America Biosimilars Market Value Forecast, by Product, 2017-2027

10.3. North America Biosimilars Market Value Forecast, by Indication, 2017-2027

10.4. North America Biosimilars Market Value Forecast, by Country, 2017-2027

10.5. North America Biosimilars Market Attractiveness Analysis

11. Europe Biosimilars Market Analysis and Forecast

12. Asia Pacific Biosimilars Market Analysis and Forecast

13. Latin America Biosimilars Market Analysis and Forecast

14. Middle East & Africa Biosimilars Market Analysis and Forecast

15. Competition Landscape

15.1. Competition Matrix

15.2. Market Share Analysis, by Company, 2018

15.3. Company Profiles

15.3.1. Pfizer, Inc.

15.3.2. Intas Pharmaceuticals Ltd.

15.3.3. Biocon

15.3.4. Dr. Reddy’s Laboratories Ltd.

15.3.5. Teva Pharmaceutical Industries Ltd.

15.3.6. Sandoz International GmbH (A Novartis Division)

15.3.7. Celltrion Inc.

15.3.8. Amgen, Inc.

15.3.9. STADA Arzneimittel AG

15.3.10. Apotex Inc. (Apobiologix)

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/vgif0f

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900